New research provides hope for treating Huntington's disease. Scientists used baker's yeast to identify genes involved in translation that may protect against Huntington's. This suggests a potential new drug target. Separate research found the protein DRP1 is overactive in Huntington's, causing excessive mitochondrial division. Reducing DRP1 activity restored mitochondrial health and improved neuron survival, indicating DRP1 inhibition could delay disease onset. Understanding the disease mechanisms allows developing better treatments and possibly a cure.